In the crowded cardio space, it’s David vs. Goliath for small biotechs

The cardiovascular space is filled with some of the biggest pharma and biotech players in the world. Not only did the weight loss phenomenon Wegovy score a cardiovascular indication last year, but giants like Merck & Co. are making moves, too.